Efficacy of pembrolizumab monotherapy for advanced Gastric/Gastroesophageal junction cancer with programmed death ligand 1 combined positive score >= 10

by biblioteca on 10 de maig de 2021 with No hi ha comentaris

Wainberg, Z. A., Fuchs, C. S., Tabernero, J., Shitara, K., Muro, K., Van Cutsem, E., et al. (2021). Efficacy of pembrolizumab monotherapy for advanced Gastric/Gastroesophageal junction cancer with programmed death ligand 1 combined positive score >= 10. Clinical Cancer Research, 27(7), 1923-1931. https://doi.org/10.1158/1078-0432.CCR-20-2980